Glaxosmithkline Pharmaceuticals Ltd. Financials: Check Share Price, Balance Sheet, Annual Report and Quarterly Results for Company Analysis

Glaxosmithkline Pharmaceuticals Ltd. is a leading pharmaceutical company in India, providing a wide range of healthcare products to its customers.  We will provide a comprehensive analysis of Glaxosmithkline Pharmaceuticals Ltd.'s stock performance and key financial indicators for long-term stock investors looking for stock analysis.

Glaxosmithkline Pharmaceuticals Ltd. Share Price

Glaxosmithkline Pharmaceuticals Ltd.'s share price has been consistently increasing over the years due to the company's strong financial performance and growth prospects. The company has a stable business model and a diverse range of clients, which provides investors with a sense of security and stability. Investors can use Ticker pre-built screening tools to track Glaxosmithkline Pharmaceuticals Ltd.'s share price and compare it with other companies in the industry.

Glaxosmithkline Pharmaceuticals Ltd. Balance Sheet

Glaxosmithkline Pharmaceuticals Ltd.'s balance sheet is a reflection of the company's financial health and stability. The company has a strong balance sheet with a healthy debt-to-equity ratio and a high current ratio. Ticker premium features allow fair value calculation using tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis. These tools provide investors with a comprehensive understanding of the company's financial position and help them make informed investment decisions.

Glaxosmithkline Pharmaceuticals Ltd. Annual Report

Glaxosmithkline Pharmaceuticals Ltd.'s annual reports provide detailed information about the company's operations, financial performance, and future prospects. Investors can download the annual reports from Ticker and analyze the company's performance over the years. The annual report also includes information about the company's management team, corporate governance practices, and sustainability initiatives.

Glaxosmithkline Pharmaceuticals Ltd. Dividend

Glaxosmithkline Pharmaceuticals Ltd. has a consistent track record of paying dividends to its shareholders. The company has a dividend payout ratio of over 30%, which indicates that it is committed to sharing its profits with its shareholders. Investors can track Glaxosmithkline Pharmaceuticals Ltd.'s dividend history using Ticker pre-built screening tools and compare it with other companies in the industry.

Glaxosmithkline Pharmaceuticals Ltd. Quarterly Result

Glaxosmithkline Pharmaceuticals Ltd.'s quarterly results provide an insight into the company's performance over a shorter period. The company's revenue and profits can be affected by various factors such as changes in government policies, fluctuations in commodity prices, and global economic conditions. Ticker premium features allow fair value calculation using tools such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis. These tools provide investors with a comprehensive understanding of the company's financial position and help them make informed investment decisions.

Glaxosmithkline Pharmaceuticals Ltd. Stock Price

Glaxosmithkline Pharmaceuticals Ltd.'s stock price is influenced by various factors such as the company's financial performance, market conditions, and investor sentiment. Investors can track Glaxosmithkline Pharmaceuticals Ltd.'s stock price using our pre-built screening tools and compare it with other companies in the industry. 

Glaxosmithkline Pharmaceuticals Ltd. Price Chart

Glaxosmithkline Pharmaceuticals Ltd.'s price chart provides a visual representation of the company's stock performance over a period of time. Investors can use our pre-built screening tools to analyze Glaxosmithkline Pharmaceuticals Ltd.'s price chart and compare it with other companies in the industry. 

Glaxosmithkline Pharmaceuticals Ltd. News

Glaxosmithkline Pharmaceuticals Ltd.'s news section provides investors with the latest updates about the company's operations, financial performance, and future prospects. Investors can stay informed about the company's developments by regularly checking the news section on Ticker.

Glaxosmithkline Pharmaceuticals Ltd. Concall Transcripts

Glaxosmithkline Pharmaceuticals Ltd.'s concall transcripts provide investors with an opportunity to listen to the management team's views on the company's performance and future prospects. Investors can download the concall transcripts from Ticker and gain valuable insights into the company's operations.

Glaxosmithkline Pharmaceuticals Ltd. Investor Presentations

Glaxosmithkline Pharmaceuticals Ltd.'s investor presentations provide a comprehensive overview of the company's operations, financial performance, and future prospects. Investors can download the investor presentations from Ticker and gain a deeper understanding of the company's business model and growth prospects.

Glaxosmithkline Pharmaceuticals Ltd. Promoters

Glaxosmithkline Pharmaceuticals Ltd.'s promoters include some of the leading business conglomerates in India. The company has a strong backing from its promoters, which provides investors with a sense of security and stability.

Glaxosmithkline Pharmaceuticals Ltd. Shareholders

Glaxosmithkline Pharmaceuticals Ltd.'s shareholders include retail investors, institutional investors, and the company's promoters. The company has a diverse shareholder base, which indicates that it is a popular investment choice among investors.

Glaxosmithkline Pharmaceuticals Ltd. ROCE

Return on Capital Employed (ROCE) is a pivotal financial metric that indicates a company's efficiency in generating profits from its capital investments. At our stock analysis page, you can access the ROCE data for Glaxosmithkline Pharmaceuticals Ltd. in the financials table or ratio section. This information helps investors evaluate the company's ability to utilize its capital effectively and compare its performance to industry benchmarks.

Glaxosmithkline Pharmaceuticals Ltd. EBITDA

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is a significant metric that reflects the operational profitability of a company. On our stock analysis page, you can find EBITDA data for Glaxosmithkline Pharmaceuticals Ltd. in the financials table or ratio section. Analyzing the EBITDA provides insights into the company's core business profitability and its capacity to generate cash flow.

Glaxosmithkline Pharmaceuticals Ltd. DPS

Dividends Per Share (DPS) is a financial metric that indicates the amount of dividends distributed to each outstanding share. You can find DPS data for Glaxosmithkline Pharmaceuticals Ltd. on our stock analysis page, available in the financials table or ratio section. Understanding the DPS can assist investors in evaluating the company's dividend distribution policy and its potential as an income-generating investment.

Glaxosmithkline Pharmaceuticals Ltd. EPS

Earnings Per Share (EPS) is a crucial metric that measures a company's profitability on a per-share basis. Investors can find the EPS data for Glaxosmithkline Pharmaceuticals Ltd. on our stock analysis page in the financials table or ratio section. Analyzing the EPS provides valuable insights into the company's earnings performance and growth potential, aiding investors in making informed investment decisions.